Found: 54
Select item for more details and to access through your institution.
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 2987, doi. 10.1007/s00432-022-04188-7
- By:
- Publication type:
- Article
Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules.
- Published in:
- Journal of Extracellular Vesicles, 2019, v. 8, n. 1, p. 1, doi. 10.1080/20013078.2019.1663666
- By:
- Publication type:
- Article
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00866-6
- By:
- Publication type:
- Article
Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer.
- Published in:
- Pathology & Oncology Research, 2009, v. 15, n. 4, p. 651, doi. 10.1007/s12253-009-9167-8
- By:
- Publication type:
- Article
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229435
- By:
- Publication type:
- Article
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231167818
- By:
- Publication type:
- Article
KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 4, p. 1381, doi. 10.1245/s10434-012-2754-z
- By:
- Publication type:
- Article
Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 1, p. 41, doi. 10.1111/ajco.12419
- By:
- Publication type:
- Article
Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. 135, doi. 10.1016/j.cllc.2021.09.002
- By:
- Publication type:
- Article
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anaplastic Lymphoma Kinase Variants and the Percentage of ALK-Positive Tumor Cells and the Efficacy of Crizotinib in Advanced NSCLC.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Genetic Evolution of Epidermal Growth Factor Receptor in Adenocarcinoma With a Bronchioloalveolar Carcinoma Component.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 3, p. 160, doi. 10.3816/CLC.2010.n.020
- By:
- Publication type:
- Article
Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients.
- Published in:
- Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00199-z
- By:
- Publication type:
- Article
Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069104
- By:
- Publication type:
- Article
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 3, p. 471, doi. 10.1007/s00262-017-2098-4
- By:
- Publication type:
- Article
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09762-1
- By:
- Publication type:
- Article
A Modified Arthroscopic Outside‐in Shoulder Release Approach for Severe Shoulder Stiffness.
- Published in:
- Orthopaedic Surgery, 2023, v. 15, n. 8, p. 2167, doi. 10.1111/os.13568
- By:
- Publication type:
- Article
Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 302, doi. 10.3390/cancers15010302
- By:
- Publication type:
- Article
Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 8, p. 1581, doi. 10.1002/1878-0261.13439
- By:
- Publication type:
- Article
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 396, doi. 10.1002/cam4.4925
- By:
- Publication type:
- Article
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 1, p. 337, doi. 10.1002/ctm2.12
- By:
- Publication type:
- Article
Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 1, p. 109, doi. 10.1007/s10585-020-10062-y
- By:
- Publication type:
- Article
Disease Flare After EGFR Tyrosine Kinase Inhibitor Cessation Predicts Poor Survival in Patients with Non-small Cell Lung Cancer.
- Published in:
- Pathology & Oncology Research, 2013, v. 19, n. 4, p. 833, doi. 10.1007/s12253-013-9651-z
- By:
- Publication type:
- Article
An integrated biomarker of PD‐L1 expression and intraepithelial CD8<sup>+</sup> T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 13, p. 1948, doi. 10.1111/1759-7714.14473
- By:
- Publication type:
- Article
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 11, p. 1619, doi. 10.1111/1759-7714.14429
- By:
- Publication type:
- Article
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 9, p. 1333, doi. 10.1111/1759-7714.14393
- By:
- Publication type:
- Article
High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 19, p. 2564, doi. 10.1111/1759-7714.14137
- By:
- Publication type:
- Article
Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1512, doi. 10.1111/1759-7714.13419
- By:
- Publication type:
- Article
Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 346, doi. 10.1111/1759-7714.13271
- By:
- Publication type:
- Article
Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 9, p. 1093, doi. 10.1111/1759-7714.12791
- By:
- Publication type:
- Article
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Everolimus synergizes with gefitinib in non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 707, doi. 10.1007/s00280-012-1946-3
- By:
- Publication type:
- Article
In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 637, doi. 10.1007/s00280-010-1347-4
- By:
- Publication type:
- Article
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149370
- By:
- Publication type:
- Article
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1001, doi. 10.1002/mc.23541
- By:
- Publication type:
- Article
Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e209077, doi. 10.1001/jamanetworkopen.2020.9077
- By:
- Publication type:
- Article
Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1515
- By:
- Publication type:
- Article
Familial association of lung cancer with liver cancer in first-degree relatives.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5813, doi. 10.2147/CMAR.S199462
- By:
- Publication type:
- Article
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01403-w
- By:
- Publication type:
- Article
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, p. 1, doi. 10.1038/s41392-023-01403-w
- By:
- Publication type:
- Article
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01403-w
- By:
- Publication type:
- Article
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-022-01286-3
- By:
- Publication type:
- Article
Lung Cancer Treatment Disparities in China: A Question in Need of an Answer.
- Published in:
- Oncologist, 2014, v. 19, n. 10, p. 1084, doi. 10.1634/theoncologist.2014-0007
- By:
- Publication type:
- Article
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00245-y
- By:
- Publication type:
- Article